Clinic versus clinic? Internecine conflicts among direct-to-consumer stem cell firms
Stem cell clinics marketing non-FDA approved therapies directly to consumers have been in various tense situations at times with the FDA or academics over the years, but more recently these stem cell clinic-related firms also appear in conflict with each other sometimes. The most notable recent example of conflict involves Dr. Christopher Centeno of Regenexx …
Clinic versus clinic? Internecine conflicts among direct-to-consumer stem cell firms Read More »
